Skip to main content
. 2022 Sep 26;2022(9):CD011642. doi: 10.1002/14651858.CD011642.pub2

15.1. Analysis.

15.1

Comparison 15: 595‐nm Pulsed‐Dye Laser (PDL) plus intralesional verapamil versus intralesional verapamil, Outcome 1: Incidence of treatment‐related adverse effects (24 weeks)